Fertility and Sterility
Volume 93, Issue 3 , Pages 681-690 , February 2010

Racial and ethnic differences in reproductive potential across the life cycle

  • Samantha F. Butts, M.D., MSCE

      Affiliations

    • Division of Infertility and Reproductive Endocrinology, University of Pennsylvania Medical School, Philadelphia, Pennsylvania
    • Corresponding Author InformationReprint requests: Samantha Butts, M.D., MSCE, 3701 Market Street, Suite 800, Philadelphia, PA 19104 (FAX: 215-349-5512).
  • ,
  • David B. Seifer, M.D.

      Affiliations

    • Genesis Fertility and Reproductive Medicine, Maimonides Medical Center, Brooklyn, New York
    • Obstetrics, Gynecology and Reproductive Sciences, Mt. Sinai School of Medicine, New York, New York

Received 27 October 2009 ,Accepted 27 October 2009.

References 

  1. U.S . Department of Health and Human Services: Office of Disease Prevention and Health Promotion—Healthy People 2010. Nasnewsletter. 2000;15:3
  2. Davidson EC, Fukushima T. The racial disparity in infant mortality. N Engl J Med. 1992;327:1022–1024
  3. Frisbie WP, Song SE, Powers DA, Street JA. The increasing racial disparity in infant mortality: respiratory distress syndrome and other causes. Demography. 2004;41:773–800
  4. Kelley E, Moy E, Dayton E. Health care quality and disparities: lessons from the first national reports. Med Care. 2005;43:I1–I2
  5. Williams DR. Race and health: basic questions, emerging directions. Ann Epidemiol. 1997;7:322–333
  6. Williams DR, Rucker TD. Understanding and addressing racial disparities in health care. Health Care Financ Rev. 2000;21:75–90
  7. Rebbeck TR, Halbert CH, Sankar P. Genetics, epidemiology, and cancer disparities: is it black and white?. J Clin Oncol. 2006;24:2164–2169
  8. Rebbeck TR, Sankar P. Ethnicity, ancestry, and race in molecular epidemiologic research. Cancer Epidemiol Biomarkers Prev. 2005;14:2467–2471
  9. Wu T, Mendola P, Buck GM. Ethnic differences in the presence of secondary sex characteristics and menarche among US girls: the Third National Health and Nutrition Examination Survey, 1988–1994. Pediatrics. 2002;110:752–757
  10. Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ, Bhapkar MV, Koch GG, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics. 1997;99:505–512
  11. Chumlea WC, Schubert CM, Roche AF, Kulin HE, Lee PA, Himes JH, et al. Age at menarche and racial comparisons in US girls. Pediatrics. 2003;111:110–113
  12. Kaplowitz P. Pubertal development in girls: secular trends. Curr Opin Obstet Gynecol. 2006;18:487–491
  13. Kimm SY, Barton BA, Obarzanek E, McMahon RP, Sabry ZI, Waclawiw MA, et al. Racial divergence in adiposity during adolescence: The NHLBI Growth and Health Study. Pediatrics. 2001;107:E34
  14. Slyper AH. The pubertal timing controversy in the USA, and a review of possible causative factors for the advance in timing of onset of puberty. Clin Endocrinol (Oxf). 2006;65:1–8
  15. Koprowski C, Ross RK, Mack WJ, Henderson BE, Bernstein L. Diet, body size and menarche in a multiethnic cohort. Br J Cancer. 1999;79:1907–1911
  16. Weaver CM, McCabe LD, McCabe GP, Novotny R, Van Loan M, Going S, et al. Bone mineral and predictors of bone mass in white, Hispanic, and Asian early pubertal girls. Calcif Tissue Int. 2007;81:352–363
  17. Novotny R, Going S, Teegarden D, Vam Loan M, McCabe G, McCabe L, et al. Hispanic and Asian pubertal girls have higher android/gynoid fat ratio than whites. Obesity (Silver Spring). 2007;15:1565–1570
  18. McDowell MA, Brody DJ, Hughes JP. Has age at menarche changed? Results from the National Health and Nutrition Examination Survey (NHANES) 1999–2004. J Adolesc Health. 2007;40:227–231
  19. Frisch RE, McArthur JW. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science. 1974;185:949–951
  20. Maclure M, Travis LB, Willett W, MacMahon B. A prospective cohort study of nutrient intake and age at menarche. Am J Clin Nutr. 1991;54:649–656
  21. Lassek WD, Gaulin SJ. Brief communication: menarche is related to fat distribution. Am J Phys Anthropol. 2007;133:1147–1151
  22. Casazza K, Goran MI, Gower BA. Associations among insulin, estrogen, and fat mass gain over the pubertal transition in African-American and European-American girls. J Clin Endocrinol Metab. 2008;93:2610–2615
  23. He Q, Horlick M, Thornton J, Wang J, Pierson RN, HesHkla S, et al. Sex and race differences in fat distribution among Asian, African-American, and Caucasian prepubertal children. J Clin Endocrinol Metab. 2002;87:2164–2170
  24. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC. The insulin-related ovarian regulatory system in health and disease. Endocr Rev. 1999;20:535–582
  25. Klein DJ, Aronson Friedman L, Harlan WR, Barton BA, Schreiber GB, Cohen RM, et al. Obesity and the development of insulin resistance and impaired fasting glucose in black and white adolescent girls: a longitudinal study. Diabetes Care. 2004;27:378–383
  26. Arslanian S. Insulin secretion and sensitivity in healthy African-American vs. American white children. Clin Pediatr (Phila). 1998;37:81–88
  27. Gower BA, Fernandez JR, Beasley TM, Shriver MD, Goran MI. Using genetic admixture to explain racial differences in insulin-related phenotypes. Diabetes. 2003;52:1047–1051
  28. Goran MI, Gower BA. Longitudinal study on pubertal insulin resistance. Diabetes. 2001;50:2444–2450
  29. Gower BA, Nagy TR, Goran MI. Visceral fat, insulin sensitivity, and lipids in prepubertal children. Diabetes. 1999;48:1515–1521
  30. Gower BA, Nagy TR, Trowbridge CA, Dezenberg C, Goran MI. Fat distribution and insulin response in prepubertal African American and white children. Am J Clin Nutr. 1998;67:821–827
  31. Blanck HM, Marcus M, Tolbert PE, Rubin C, Alden CK, Hertzberg VS, et al. Age at menarche and tanner stage in girls exposed in utero and postnatally to polybrominated biphenyl. Epidemiology. 2000;11:641–647
  32. Wolff MS, Landrigan PJ. Organochlorine chemicals and children's health. J Pediatr. 2002;140:10–13
  33. McKinney JD, Waller CL. Polychlorinated biphenyls as hormonally active structural analogues. Environ Health Perspect. 1994;102:290–297
  34. Crain DA, Janssen SJ, Edwards TM, Heindel J, Ho SM, Hunt P, et al. Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertil Steril. 2008;90:911–940
  35. Palmert MR, Boepple PA. Variation in the timing of puberty: clinical spectrum and genetic investigation. J Clin Endocrinol Metab. 2001;86:2364–2368
  36. Sharara FI, McClamrock HD. Differences in in vitro fertilization (IVF) outcome between white and black women in an inner-city, university-based IVF program. Fertil Steril. 2000;73:1170–1173
  37. Seifer DB, Zackula R, Grainger DA. Trends of racial disparities in assisted reproductive technology outcomes in black women compared with white women: Society for Assisted Reproductive Technology 1999 and 2000 vs. 2004–2006. Fertil Steril. April 14, 2009;[Epub ahead of print]
  38. Seifer DB, Frazier LM, Grainger DA. Disparity in assisted reproductive technologies outcomes in black women compared with white women. Fertil Steril. 2008;90:1701–1710
  39. Purcell K, Schembri M, Frazier LM, Rall MJ, Shen S, Croughan M, et al. Asian ethnicity is associated with reduced pregnancy outcomes after assisted reproductive technology. Fertil Steril. 2007;87:297–302
  40. Fujimoto VY, Luke B, Brown MB, Jain T, Armstrong A, Grainger DA, et al. Racial and ethnic disparities in assisted reproductive technology outcomes in the United States. Fertil Steril. December 10, 2008;[Epub ahead of print]
  41. Palep-Singh M, Picton HM, Vrotsou K, Maruthini D, Balen AH. South Asian women with polycystic ovary syndrome exhibit greater sensitivity to gonadotropin stimulation with reduced fertilization and ongoing pregnancy rates than their Caucasian counterparts. Eur J Obstet Gynecol Reprod Biol. 2007;134:202–207
  42. Dayal MB, Gindoff P, Dubey A, Spitzer TL, Bergin A, Peak D, et al. Does ethnicity influence in vitro fertilization (IVF) birth outcomes?. Fertil Steril. 2009;91:2414–2418
  43. Feinberg EC, Larsen FW, Catherino WH, Zhang J, Armstrong AY. Comparison of assisted reproductive technology utilization and outcomes between Caucasian and African American patients in an equal-access-to-care setting. Fertil Steril. 2006;85:888–894
  44. Bendikson K, Cramer DW, Vitonis A, Hornstein MD. Ethnic background and in vitro fertilization outcomes. Int J Gynaecol Obstet. 2005;88:342–346
  45. Matalliotakis I, Cakmak H, Arici A, Goumenou A, Fragouli Y, Sakkas D. Epidemiological factors influencing IVF outcome: evidence from the Yale IVF program. J Obstet Gynaecol. 2008;28:204–208
  46. Jain T, Hornstein MD. Disparities in access to infertility services in a state with mandated insurance coverage. Fertil Steril. 2005;84:221–223
  47. Jain T. Socioeconomic and racial disparities among infertility patients seeking care. Fertil Steril. 2006;85:876–881
  48. Bitler M, Schmidt L. Health disparities and infertility: impacts of state-level insurance mandates. Fertil Steril. 2006;85:858–865
  49. Centers for Disease Control and Prevention Assisted Reproductive Technology Report. 2004.
  50. Stanford JL, Hartge P, Brinton LA, Hoover RN, Brookmeyer R. Factors influencing the age at natural menopause. J Chronic Dis. 1987;40:995–1002
  51. Bromberger JT, Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prospective study of the determinants of age at menopause. Am J Epidemiol. 1997;145:124–133
  52. MacMahon B, Worcester J. Age at menopause. United States—1960–1962. Vital Health Stat. 1966;11:1–20
  53. Gold EB, Bromberger J, Crawford S, Samuels S, Greendale GA, Harlow DS, et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol. 2001;153:865–874
  54. Cooper GS, Baird DD, Darden FR. Measures of menopausal status in relation to demographic, reproductive, and behavioral characteristics in a population-based study of women aged 35–49 years. Am J Epidemiol. 2001;153:1159–1165
  55. Boulet MJ, Oddens BJ, Lehert P, Vemer HM, Visser A. Climacteric and menopause in seven South-east Asian countries. Maturitas. 1994;19:157–176
  56. Tamada T, Iwasaki H. [Age at natural menopause in Japanese women]. Nippon Sanka Fujinka Gakkai Zasshi. 1995;47:947–952
  57. Ismael NN. A study on the menopause in Malaysia. Maturitas. 1994;19:205–209
  58. Chompootweep S, Tankeyoon M, Yamarat K, Poomsuwan P, Dusitsin N. The menopausal age and climacteric complaints in Thai women in Bangkok. Maturitas. 1993;17:63–71
  59. Ramoso-Jalbuena J. Climacteric Filipino women: a preliminary survey in the Philippines. Maturitas. 1994;19:183–190
  60. Garrido-Latorre F, Lazcano-Ponce EC, Lopez-Carrillo L, Hernandez-Avila M. Age of natural menopause among women in Mexico City. Int J Gynaecol Obstet. 1996;53:159–166
  61. Gonzales GF, Villena A, De La Cruz D. Age of natural menopause among women in Lima City, Peru. Int J Gynaecol Obstet. 1997;57:69–72
  62. Beyene Y. Cultural significance and physiological manifestations of menopause. A biocultural analysis. Cult Med Psychiatry. 1986;10:47–71
  63. Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod. 2003;18:199–206
  64. Randolph JF, Sowers M, Gold EB, Mohr BA, Luborsky L, Santoro N, et al. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab. 2003;88:1516–1522
  65. Samsioe G, Bryman I, Ivarsson E. Some anthropological aspects of the climacteric syndrome. Acta Obstet Gynecol Scand Suppl. 1985;130:5–7
  66. Haines CJ, Chung TK, Leung DH. A prospective study of the frequency of acute menopausal symptoms in Hong Kong Chinese women. Maturitas. 1994;18:175–181
  67. Tang GW. The climacteric of Chinese factory workers. Maturitas. 1994;19:177–182
  68. Lock M. Contested meanings of the menopause. Lancet. 1991;337:1270–1272
  69. Lock M, Kaufert P, Gilbert P. Cultural construction of the menopausal syndrome: the Japanese case. Maturitas. 1988;10:317–332
  70. Gold EB, Sternfeld B, Kelsey JL, Brown C, Mouton C, Reame N, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol. 2000;152:463–473
  71. Freeman EW, Sammel MD, Gracia CR, Kapoor S, Lin H, Liu L, et al. Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertil Steril. 2005;83:383–392
  72. Manson JM, Sammel MD, Freeman EW, Grisso JA. Racial differences in sex hormone levels in women approaching the transition to menopause. Fertil Steril. 2001;75:297–304
  73. Gracia CR, Freeman EW, Sammel MD, Lin H, Nelson DB. The relationship between obesity and race on inhibin B during the menopause transition. Menopause. 2005;12:559–566
  74. Seifer DB, Maclaughlin DT. Mullerian inhibiting substance is an ovarian growth factor of emerging clinical significance. Fertil Steril. 2007;88:539–546
  75. Seifer DB, Maclaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertility and Sterility. 2002;77:468–471
  76. van Rooij IA, Tonkelaar I, Broekmans FJ, Looman CW, Scheffer GJ, de Jong FH, et al. Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause. 2004;11:601–606
  77. Tremellen KP, Kolo M, Gilmore A, Lekamge DN. Anti-mullerian hormone as a marker of ovarian reserve. Aust N Z J Obstet Gynaecol. 2005;45:20–24
  78. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77:357–362
  79. Butts S, Seifer DB. 6 office tests of ovarian reserve and what they can tell you. OBG Management. 2008;20:29–40
  80. Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab. 2006;91:4057–4063
  81. La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod. 2006;21:3103–3107
  82. La Marca A, Giulini S, Orvieto R, De Leo V, Volpe A. Anti-Mullerian hormone concentrations in maternal serum during pregnancy. Hum Reprod. 2005;20:1569–1572
  83. Tsepelidis S, Devreker F, Demeestere I, Flahaut A, Gervy C, Englert Y. Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod. 2007;22:1837–1840
  84. Somunkiran A, Yavuz T, Yucel O, Ozdemir I. Anti-Mullerian hormone levels during hormonal contraception in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2007;134:196–201
  85. Seifer DB, Golub ET, Lambert-Messerlian G, Benning L, Anastos K, et al. Variations in serum mullerian inhibiting substance between white, black, and Hispanic women. Fertil Steril. 2009;92:1674–1678
  86. Freeman EW, Gracia CR, Sammel MD, Lin H, Lim LC, Strauss JF. Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril. 2007;87:101–106
  87. Grisso JA, Freeman EW, Maurin E, Garcia-Espana B, Berlin JA. Racial differences in menopause information and the experience of hot flashes. J Gen Intern Med. 1999;14:98–103
  88. Freeman EW, Sammel MD, Lin H, Gracia CR, Pien GW, Nelson DB, et al. Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol. 2007;110:230–240
  89. Freeman EW, Grisso JA, Berlin J, Sammel M, Garcia-Espana B, Hollander L. Symptom reports from a cohort of African American and white women in the late reproductive years. Menopause. 2001;8:33–42
  90. Gold EB, Colvin A, Avis N, Bromberger J, Greendale GA, Powell L, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health. 2006;96:1226–1235
  91. Goldsmith LT, Kim S, Lasser NL, McGovern P, Weiss G. Menopausal symptom relief in women's health initiative participants given estrogen: reduced efficacy of estrogen in black women. Reprod Sci. 2009;16
  92. Kaplowitz PB, Slora EJ, Wasserman RC, Pedlow SE, Herman-Giddens ME. Earlier onset of puberty in girls: relation to increased body mass index and race. Pediatrics. 2001;108:347–353
  93. Adair LS, Gordon-Larsen P. Maturational timing and overweight prevalence in US adolescent girls. Am J Public Health. 2001;91:642–644
  94. Wang Y. Is obesity associated with early sexual maturation? A comparison of the association in American boys versus girls. Pediatrics. 2002;110:903–910
  95. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA. 2004;291:2847–2850
  96. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295:1549–1555
  97. Census of Population Public Law 94–171 Redistricting Data File: Race, US Census Bureau.
  98. Grieco EM, Cassid RC. Overview of Race and Hispanic Origin: Census 200 Brief, US Census Bureau.
  99. Stephen EH, Chandra A. Declining estimates of infertility in the United States: 1982–2002. Fertil Steril. 2006;86:516–523
  100. Maheshwari A, Stofberg L, Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology—a systematic review. Hum Reprod Update. 2007;13:433–444
  101. Wang JX, Davies MJ, Norman RJ. Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res. 2002;10:551–554
  102. Fedorcsak P, Storeng R, Dale PO, Tanbo T, Abyholm T. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand. 2000;79:43–48

 Edward E. Wallach, M.D.Associate Editor

 S.F.B. has nothing to disclose. D.B.S. receives royalties related to the use of Mullerian inhibiting substance/Anti-mullerian hormone for predicting ovarian response in women with infertility.

PII: S0015-0282(09)03967-3

doi: 10.1016/j.fertnstert.2009.10.047

Fertility and Sterility
Volume 93, Issue 3 , Pages 681-690 , February 2010